Advances in pediatric antituberculosis therapy: toward child-friendly all-in-one dosage forms

Czech version

Authors: Karolína Doležalová
Authors‘ workplace: Pediatrická klinika, 1. lékařská fakulta, Univerzita Karlova a Fakultní Thomayerova nemocnice, Praha ;
Published in: Čes-slov Pediat 2025; 80 (4): 195-196.
Category:
doi: https://doi.org/10.55095/CSPediatrie2025/032

Overview

Doležalová K. advances in pediatric antituberculosis therapy: toward child-friendly all-in-one dosage forms

contemporary pharmaceutical agents, specifically orodispersible tablets, are now entering the management of tuberculosis in children. the pharmaceuticals are available in two forms: either in combination (isoniaside+rifamp icin+pyrazinamide, isoniazid+rifampicin) or as monotherapy (isoniaside, ethambutol). the treatment is primarily indicated for the youngest age groups.